Oxytocin in the Treatment of Psychiatric Disorders

被引:4
|
作者
Kagizman, Salim Cagatay [1 ]
Hocaoglu, Cicek [2 ]
机构
[1] Hitit Univ, Erol Olcok Training & Res Hosp, Dept Psychiat, Corum, Turkiye
[2] Recep Tayyip Erdogan Univ, Fac Med, Dept Psychiat, Rize, Turkiye
来源
MEDENIYET MEDICAL JOURNAL | 2023年 / 38卷 / 03期
关键词
Psychiatric disorders; oxytocin; schizophrenia; resistance to treatment; autism; ADJUNCTIVE INTRANASAL OXYTOCIN; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; SCHIZOPHRENIA; METAANALYSIS; REACTIVITY; WITHDRAWAL; WOMEN;
D O I
10.4274/MMJ.galenos.2023.13707
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxytocin is a peptide hormone that is most known for its role in reproduction. However, many effects other than reproduction have been defined. The lifetime prevalence of mental disorders is approximately 20%, and they have a significant ratio among the diseases that lead to disability. Treatment resistance may cause the mental disorder to become chronic and increase disability. With the examination of the oxytocinergic system, both the elucidation of the etiology of the diseases and their evaluation as a new treatment option have come to the fore. In various studies, it has been desired to create a more effective treatment model by measuring the level of oxytocin in psychiatric disorders, examining its receptor, and applying exogenous oxytocin in the treatment. In this review, an overview of oxytocin's efficacy in treatment is presented by considering the relationship between psychiatric disorders and the oxytocinergic system.
引用
收藏
页码:218 / 231
页数:14
相关论文
共 50 条
  • [41] Management of smoking cessation in patients with psychiatric disorders
    Fagerstrom, Karl
    Aubin, Henri-Jean
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (02) : 511 - 518
  • [42] Sleep in Psychiatric Disorders: Where Are We Now?
    Lee, Elliott Kyung
    Douglass, Alan B.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2010, 55 (07): : 403 - 412
  • [43] Clostridiales are predominant microbes that mediate psychiatric disorders
    Li, Jingjing
    Ma, Yunlong
    Bao, Zhiwei
    Gui, Xiaohua
    Li, Andria N.
    Yang, Zhongli
    Li, Ming D.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2020, 130 : 48 - 56
  • [44] The Role of rTMS in the Treatment of Psychiatric Disorders Other than Major Depression
    Grammer, Geoffrey
    Green, Vanessa
    Amin, Rohul
    Alampay, Miguel
    PSYCHIATRIC ANNALS, 2014, 44 (06) : 293 - 298
  • [45] Advances in the treatment of psychiatric disorders in long-term care homes
    Conn, David K.
    Seitz, Dallas P.
    CURRENT OPINION IN PSYCHIATRY, 2010, 23 (06) : 516 - 521
  • [46] Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: A comprehensive review
    Bersani, Francesco Saverio
    Minichino, A.
    Enticott, P. G.
    Mazzarini, L.
    Khan, N.
    Antonacci, G.
    Raccah, R. N.
    Salviati, M.
    Delle Chiaie, R.
    Bersani, G.
    Fitzgerald, P. B.
    Biondi, M.
    EUROPEAN PSYCHIATRY, 2013, 28 (01) : 30 - 39
  • [48] The placebo arm in clinical studies for treatment of Psychiatric Disorders: A Regulatory Dilemma
    Gispen-de Wied, Christine
    Stoyanova, Violeta
    Yu, Yang
    Isaac, Maria
    Pani, Luca
    de Andres-Trelles, Fernando
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (11) : 804 - 811
  • [49] The role of oxytocin and vasopressin in central nervous system activity and mental disorders
    Wojciak, Pawel
    Remlinger-Molenda, Agnieszka
    Rybakowski, Janusz
    PSYCHIATRIA POLSKA, 2012, 46 (06) : 1043 - 1052
  • [50] Sex matters: The impact of oxytocin on healthy conditions and psychiatric disorders
    Marazziti, Donatella
    Carter, C. Sue
    Carmassi, Claudia
    Della Vecchia, Alessandra
    Mucci, Federico
    Pagni, Giovanni
    Carbone, Manuel G.
    Baroni, Stefano
    Giannaccini, Gino
    Palego, Lionella
    Dell'Osso, Liliana
    COMPREHENSIVE PSYCHONEUROENDOCRINOLOGY, 2023, 13